• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respir Res . Artificial intelligence-based analysis of the spatial distribution of abnormal computed tomography patterns in SARS-CoV-2 pneumonia: as

tetano

Editor, Senior Moderator
Respir Res


. 2024 Jan 10;25(1):24.
doi: 10.1186/s12931-024-02673-w. Artificial intelligence-based analysis of the spatial distribution of abnormal computed tomography patterns in SARS-CoV-2 pneumonia: association with disease severity

Yusuke Kataoka[SUP] 1 [/SUP], Naoya Tanabe[SUP] 2 [/SUP], Masahiro Shirata[SUP] 1 [/SUP], Nobuyoshi Hamao[SUP] 1 3 [/SUP], Issei Oi[SUP] 1 3 [/SUP], Tomoki Maetani[SUP] 1 [/SUP], Yusuke Shiraishi[SUP] 1 [/SUP], Kentaro Hashimoto[SUP] 1 [/SUP], Masatoshi Yamazoe[SUP] 1 [/SUP], Hiroshi Shima[SUP] 1 [/SUP], Hitomi Ajimizu[SUP] 1 [/SUP], Tsuyoshi Oguma[SUP] 1 4 [/SUP], Masahito Emura[SUP] 4 [/SUP], Kazuo Endo[SUP] 5 [/SUP], Yoshinori Hasegawa[SUP] 6 [/SUP], Tadashi Mio[SUP] 7 [/SUP], Tetsuhiro Shiota[SUP] 8 [/SUP], Hiroaki Yasui[SUP] 9 [/SUP], Hitoshi Nakaji[SUP] 10 [/SUP], Michiko Tsuchiya[SUP] 11 [/SUP], Keisuke Tomii[SUP] 12 [/SUP], Toyohiro Hirai[SUP] 1 [/SUP], Isao Ito[SUP] 13 14 [/SUP]



Affiliations
Abstract

Background: The substantial heterogeneity of clinical presentations in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia still requires robust chest computed tomography analysis to identify high-risk patients. While extension of ground-glass opacity and consolidation from peripheral to central lung fields on chest computed tomography (CT) might be associated with severely ill conditions, quantification of the central-peripheral distribution of ground glass opacity and consolidation in assessments of SARS-CoV-2 pneumonia remains unestablished. This study aimed to examine whether the central-peripheral distributions of ground glass opacity and consolidation were associated with severe outcomes in patients with SARS-CoV-2 pneumonia independent of the whole-lung extents of these abnormal shadows.
Methods: This multicenter retrospective cohort included hospitalized patients with SARS-CoV-2 pneumonia between January 2020 and August 2021. An artificial intelligence-based image analysis technology was used to segment abnormal shadows, including ground glass opacity and consolidation. The area ratio of ground glass opacity and consolidation to the whole lung (GGO%, CON%) and the ratio of ground glass opacity and consolidation areas in the central lungs to those in the peripheral lungs (GGO(C/P)) and (CON(C/P)) were automatically calculated. Severe outcome was defined as in-hospital death or requirement for endotracheal intubation.
Results: Of 512 enrolled patients, the severe outcome was observed in 77 patients. GGO% and CON% were higher in patients with severe outcomes than in those without. Multivariable logistic models showed that GGO(C/P), but not CON(C/P), was associated with the severe outcome independent of age, sex, comorbidities, GGO%, and CON%.
Conclusion: In addition to GGO% and CON% in the whole lung, the higher the ratio of ground glass opacity in the central regions to that in the peripheral regions was, the more severe the outcomes in patients with SARS-CoV-2 pneumonia were. The proposed method might be useful to reproducibly quantify the extension of ground glass opacity from peripheral to central lungs and to estimate prognosis.

Keywords: COVID-19; Central area; Ground glass opacity; Peripheral area; Pneumonia; Quantitative analysis.

 
Back
Top Bottom